Identification of antigenic proteins associated with trichloroethylene-induced autoimmune disease by serological

Jianjun Liu1, Xiumei Xing, Haiyan Huang

  • 1Key Laboratory of Modern Toxicology of Shenzhen, Shenzhen Center for Disease Control and Prevention, No. 21, Rd 1st Tianbei, 518020 Shenzhen, PR China.

Insights

Trichloroethylene (TCE) exposure can trigger autoimmune diseases. Researchers identified specific autoantigens in patients with TCE-induced dermatitis, revealing distinct antibody profiles during disease stages for potential diagnostic biomarkers.

Area of Science:

  • Toxicology
  • Immunology
  • Proteomics

Background:

  • Trichloroethylene (TCE) is linked to autoimmune diseases, but underlying mechanisms and specific autoantigens remain unidentified.
  • Previous research detected protein adducts but failed to identify the specific proteins involved in TCE-induced autoimmunity.

Purpose of the Study:

  • To screen and identify autoantigens implicated in trichloroethylene-induced autoimmune diseases.
  • To investigate differences in autoantibody profiles between active disease and healed stages.

Main Methods:

  • Serological proteome analysis (SERPA) was employed using sera from healthy donors, TCE-induced exfoliative dermatitis patients, and healed patients.
  • Proteins with high immunogenicity were identified using MALDI-TOF-MS and tandem mass spectrometry.
  • Western blot analysis confirmed the reactivity of identified autoantigens with patient sera.

Main Results:

  • Six autoantigens were identified, including Enoyl Coenzyme A hydratase peroxisoma 1, lactate dehydrogenase B, Purine nucleoside phosphorylase, ribosomal protein P0, proteasome activator subunit 1 isoform 1, and NM23.
  • NM23 showed reactivity exclusively with sera from patients with active TCE-induced dermatitis.
  • Distinct autoantibody profiles were observed between active disease and healed stages.

Conclusions:

  • The study identified specific autoantigens associated with trichloroethylene-induced autoimmune diseases.
  • Autoantibody profiles differ between active and healed stages of the disease, suggesting potential biomarkers for diagnosis and prognosis.
  • These findings contribute to understanding TCE toxicity mechanisms and offer insights for clinical management.

Related Concept Videos